Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-May-23 10:00 PM View:  | Insulet Corp (PODD) | 23-May-23 | Grant | 843 | -- | -- | 16% 5.17K to 6.01K | |
| 26-May-22 4:11 PM View: | Insulet Corp (PODD) | 24-May-22 | Grant | 1,009 | -- | -- | 24% 4.16K to 5.17K | |
| 28-May-21 4:11 PM View: | Insulet Corp (PODD) | 27-May-21 | Grant | 808 | -- | -- | 24% 3.35K to 4.16K | |
| 14-May-21 4:06 PM View: | Insulet Corp (PODD) | 13-May-21 | Market Sale | 933 | $231.42 | $215,915.00 | (22%) 4.28K to 3.35K | 2% |
| 01-Jun-20 5:03 PM View: | Insulet Corp (PODD) | 28-May-20 | Grant | 1,029 | -- | -- | 32% 3.25K to 4.28K | |
| 04-May-20 4:26 PM View: | Insulet Corp (PODD) | 01-May-20 | Market Sale (Planned) | 863 | $196.82 | $169,856.00 | (21%) 4.12K to 3.25K | |
| 04-May-20 4:26 PM View: | Insulet Corp (PODD) | 30-Apr-20 | Market Sale (Planned) | 796 | $195.54 | $155,650.00 | (16%) 4.91K to 4.12K | |
| 03-Jun-19 5:47 PM View: | Insulet Corp (PODD) | 30-May-19 | Grant | 1,726 | -- | -- | 54% 3.19K to 4.91K | |
| 29-Jan-19 4:13 PM View: | Insulet Corp (PODD) | 25-Jan-19 | Grant | 3,187 | -- | -- | 100% 0 to 3.19K | |
| 09-May-18 6:12 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-May-18 | Market Sale (Planned) | 5,000 | $83.12 | $415,625.00 | (10%) 48.28K to 43.28K | (39%) |
| 03-May-18 7:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-May-18 | Payment of Exercise | 1,320 | $80.08 | $105,706.00 | (3%) 49.6K to 48.28K | (44%) |
| 03-May-18 7:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-May-18 | Option Exercise | 15,000 | $7.05 | $105,750.00 | 43% 34.6K to 49.6K | |
| 08-May-17 8:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-May-17 | Market Sale (Planned) | 5,000 | $53.98 | $269,900.00 | (13%) 39.6K to 34.6K | (114%) |
| 05-May-17 1:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-May-17 | Payment of Exercise | 952 | $53.37 | $50,808.20 | (2%) 40.55K to 39.6K | (117%) |
| 05-May-17 1:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-May-17 | Option Exercise | 15,000 | $3.40 | $51,000.00 | 59% 25.55K to 40.55K | |
| 09-Aug-16 6:05 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Aug-16 | Market Sale (Planned) | 5,000 | $48.54 | $242,700.00 | (16%) 30.55K to 25.55K | (138%) |
| 05-May-16 3:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-May-16 | Payment of Exercise | 1,022 | $45.05 | $46,041.10 | (3%) 31.58K to 30.55K | (157%) |
| 05-May-16 3:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-May-16 | Option Exercise | 15,000 | $3.07 | $46,050.00 | 90% 16.58K to 31.58K | |
| 10-Apr-15 5:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Apr-15 | Payment of Exercise | 1,696 | $42.09 | $71,384.60 | (9%) 18.27K to 16.58K | (175%) |
| 10-Apr-15 5:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Apr-15 | Option Exercise | 15,000 | $4.76 | $71,400.00 | 458% 3.27K to 18.27K | |
| 14-May-14 2:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-May-14 | Payment of Exercise | 10,258 | $14.47 | $148,433.00 | (76%) 13.53K to 3.27K | (700%) |
| 14-May-14 2:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-May-14 | Option Exercise | 12,000 | $12.37 | $148,440.00 | 784% 1.53K to 13.53K | |
| 14-Feb-14 7:59 PM View: | Avanir Pharmaceuticals (AVNR) | 12-Feb-14 | Grant | 21,700 | -- | -- | 37% 58.35K to 80.05K | |
| 03-Oct-13 8:53 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 2,100 | $125.00 | $262,500.00 | (100%) 2.1K to 0 | |
| 31-Jul-13 7:48 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 30-Jul-13 | Market Sale (Planned) | 1,500 | $131.26 | $196,890.00 | (42%) 3.6K to 2.1K | 6% |
| 02-Jul-13 6:53 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Jul-13 | Market Sale (Planned) | 5,000 | $132.63 | $663,150.00 | (58%) 8.6K to 3.6K | 7% |
| 21-Jun-13 8:10 AM View: | Onyx Pharmaceuticals Inc. (ONXX) | 19-Jun-13 | Market Sale (Planned) | 1,000 | $88.25 | $88,250.00 | (10%) 9.6K to 8.6K | (41%) |
| 01-Apr-13 5:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Mar-13 | Payment of Exercise | 10,469 | $12.15 | $127,198.00 | (87%) 12.0K to 1.53K | (853%) |
| 01-Apr-13 5:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Mar-13 | Option Exercise | 12,000 | $10.60 | $127,200.00 | 100% 0 to 12.0K | |
| 01-Apr-13 7:40 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 28-Mar-13 | Grant | 2,100 | -- | -- | 28% 7.5K to 9.6K | |
| 12-Mar-13 4:18 PM View: | Avanir Pharmaceuticals (AVNR) | 11-Mar-13 | Grant | 58,350 | -- | -- | 100% 0 to 58.35K | |
| 03-Dec-12 5:01 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 28-Nov-12 | Market Sale | 3,964 | $75.00 | $297,300.00 | (35%) 11.46K to 7.5K | (65%) |
| 27-Jul-12 7:54 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 25-Jul-12 | Grant | 1,500 | -- | -- | 15% 9.96K to 11.46K | |
| 03-Apr-12 8:38 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 30-Mar-12 | Grant | 3,000 | -- | -- | 43% 6.96K to 9.96K | |
| 04-Apr-11 8:33 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 31-Mar-11 | Grant | 3,000 | -- | -- | 76% 3.96K to 6.96K | |
| 28-May-10 6:39 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 26-May-10 | Grant | 1,000 | -- | -- | 34% 2.96K to 3.96K | |
| 11-May-10 9:00 PM View: | Edwards Lifesciences Corp. (EW) | 11-May-10 | Market Sale | 3,000 | $99.75 | $299,250.00 | (15%) 19.69K to 16.69K | (424%) |
| 11-May-10 9:00 PM View: | Edwards Lifesciences Corp. (EW) | 10-May-10 | Market Sale | 3,000 | $101.17 | $303,510.00 | (13%) 22.69K to 19.69K | (416%) |
| 02-Apr-10 7:08 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 31-Mar-10 | Grant | 2,000 | -- | -- | 207% 0.96K to 2.96K | |
| 16-Feb-10 4:03 PM View: | Edwards Lifesciences Corp. (EW) | 11-Feb-10 | Option Exercise | 10,000 | $30.43 | $304,300.00 | 40% 25.16K to 35.16K | |
| 16-Feb-10 4:03 PM View: | Edwards Lifesciences Corp. (EW) | 11-Feb-10 | Market Option Sale | 10,000 | $85.44 | $854,400.00 | (28%) 35.16K to 25.16K | (511%) |
| 09-Nov-09 7:39 PM View: | Edwards Lifesciences Corp. (EW) | 09-Nov-09 | Option Exercise | 10,000 | $30.43 | $304,300.00 | 40% 25.14K to 35.15K | |
| 09-Nov-09 7:39 PM View: | Edwards Lifesciences Corp. (EW) | 09-Nov-09 | Market Option Sale | 10,000 | $80.05 | $800,500.00 | (28%) 35.15K to 25.14K | (552%) |
| 29-Oct-09 8:53 PM View: | Edwards Lifesciences Corp. (EW) | 29-Oct-09 | Gift | 250 | -- | -- | (< 1%) 25.39K to 25.14K | |
| 29-Oct-09 8:53 PM View: | Edwards Lifesciences Corp. (EW) | 27-Oct-09 | Option Exercise | 10,000 | $30.43 | $304,300.00 | 39% 25.39K to 35.4K | |
| 29-Oct-09 8:53 PM View: | Edwards Lifesciences Corp. (EW) | 27-Oct-09 | Market Option Sale | 10,000 | $76.93 | $769,300.00 | (28%) 35.4K to 25.39K | (579%) |
| 13-May-09 4:04 PM View: | Edwards Lifesciences Corp. (EW) | 12-May-09 | Market Sale | 3,000 | $62.94 | $188,820.00 | (11%) 28.23K to 25.23K | (730%) |
| 13-May-09 4:04 PM View: | Edwards Lifesciences Corp. (EW) | 11-May-09 | Market Sale | 3,000 | $63.00 | $189,000.00 | (10%) 31.23K to 28.23K | (729%) |
| 11-May-09 9:39 PM View: | Edwards Lifesciences Corp. (EW) | 07-May-09 | Grant | 1,900 | -- | -- | 6% 29.33K to 31.23K | |
| 02-Apr-09 8:32 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 31-Mar-09 | Grant | 964 | -- | -- | 100% 0 to 0.96K |